Clinical trials
Completed Diabetes Mellitus, Type 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
468 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 5 |
| 2004 | 5 |
| 2005 | 7 |
| 2006 | 6 |
| 2007 | 7 |
| 2008 | 20 |
| 2009 | 12 |
| 2010 | 21 |
| 2011 | 17 |
| 2012 | 17 |
| 2013 | 25 |
| 2014 | 21 |
| 2015 | 20 |
| 2016 | 13 |
| 2017 | 24 |
| 2018 | 21 |
| 2019 | 29 |
| 2020 | 30 |
| 2021 | 28 |
| 2022 | 29 |
| 2023 | 40 |
| 2024 | 42 |
| 2025 | 18 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 468 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 62 |
| Eli Lilly and Company | 27 |
| AstraZeneca | 20 |
| Jiangsu HengRui Medicine Co., Ltd. | 19 |
| Sanofi | 19 |
| Boehringer Ingelheim | 16 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 11 |
| Shandong Suncadia Medicine Co., Ltd. | 11 |
| Sun Yat-sen University | 9 |
| Shanghai Zhongshan Hospital | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 468 |
| Diabetes Mellitus | 74 |
| Obesity | 27 |
| Overweight | 15 |
| Diabetes Mellitus, Type 1 | 11 |
| Insulin Resistance | 10 |
| Diabetic Nephropathies | 9 |
| Coronary Artery Disease | 7 |
| Non-alcoholic Fatty Liver Disease | 6 |
| Cognitive Dysfunction | 5 |
Trials
Showing 1 to 25 of 468. Each trial links to its page on Pharma Observatory.
368 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.